Your cart

There are no items in your shopping cart

TH 1834

Based on 2435 publications in PubMed 10 10 2435

Axon 2339

CAS [2108830-09-5]

MF C33H40N6O3.2HCl
MW 641.63

  • Purity: 99%
  • Soluble in water and DMSO

TH 1834

Description

Tip60 histone acetyltransferase inhibitor. Treating cells with TH1834 results in apoptosis and increased unrepaired DNA damage (following ionizing radiation treatment) in breast cancer but not control cell lines. Furthermore, TH 1834 did not affect the activity of related HAT MOF, as indicated by H4K16Ac, demonstrating specificity.

Order
Size Unit Price Stock
5 mg €140.00 In Stock
25 mg €520.00 In Stock
Need more? Bulk Inquiry

Related Products

Axon ID Name Description From price
1490 Anacardic acid A HAT inhibitor €60.00
1781 C 646 HAT inhibitor (p300/CBP selective) €60.00
1785 MG 149 HAT inhibitor (Tip60 and MOZ specific) €90.00
2208 Gallic acid Multi-affinity drug. Antioxidant. €50.00
2319 L 002 Inhibitor of p300 HAT (KAT3B) and p53 acetylation €80.00
2568 EML 425 Potent reversible dual inhibitor of CBP and p300 (HAT/KAT3) €95.00
2765 CPTH2 HAT inhibitor (Gcn5p specific) €125.00
2969 WM-1119 Highly potent and selective KAT6A inhibitor €130.00
3959 JG-2016 First inhibitor of the HAT1 enzyme complex €140.00
4011 MC4171 First-in-class potent and selective KAT8 inhibitor €130.00

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Newsletter
Give Feedback
 
Send E-mail

Customer Support

About Axon Medchem

Download Product Catalog

Download the Axon Ligands™ catalogue 2021 Spring Edition

Follow Us

© 2016 Axon Medchem. All Rights Reserved.

Send us a message

×

Contact Us

* Required Fields

Please wait...